SCN2A and Epileptic encephalopathy: STXBP1 and SCN2A mutations have been described in patients with epileptic encephalopathies who show myoclonic, atonic, and atypical absence seizures1–5,7,8, although our model (Fig. 9b) might also cover typical absence epilepsy, as described.